Society for Immunotherapy of Cancer (SITC)

What Society for Immunotherapy of Cancer (SITC) does

SITC (Society for Immunotherapy of Cancer) is a 501(c)(6) nonprofit professional medical society founded in 1984 and headquartered in Milwaukee, Wisconsin. It is the world's leading member-driven organization exclusively dedicated to cancer immunotherapy, serving oncologists, hematologists, immunotherapy researchers, translational scientists, oncology nurses and advanced practice providers, pharmacists, medical trainees, patient advocates, and industry/biotech professionals across more than 100 countries. The society operates a diversified portfolio of programmatic offerings anchored by the flagship Annual Meeting (held since 1985; 40th Anniversary in 2025 with over 1,300 abstract submissions; 41st scheduled for November 4-8, 2026 in Phoenix), SITC OnDemand (a self-serve streaming video library of 1,300+ sessions and 700+ hours of content), the open-access peer-reviewed Journal for ImmunoTherapy of Cancer (JITC) published in partnership with BMJ, the Advances in Cancer Immunotherapy (ACI) webinar series, Clinical Practice Guidelines, the Certificate in Cancer Immunotherapy, fellowships and grants (including the NCI Immunotherapy Fellowship and SITC Sparkathon), and specialized summits covering computational immuno-oncology, PD-1/VEGF bispecifics, and autoimmunity.

SITC does not develop proprietary technology products. Its digital infrastructure consists of the SITC OnDemand streaming platform (accessible on any device with search, filter, bookmark, and speaker-follow features), the SITC CONNECT online community, and standard web authentication via a Higher Logic-powered member portal. No public API, SDK, or developer-facing platform is offered. Revenue is generated through five primary streams: tiered annual membership dues ($0-$500 across LMIE, Patient, Student/Emeritus/Allied Health/Patient Advocate at $100, Regular at $400, and Industry-Regular at $500), standalone SITC OnDemand subscriptions ($150-$600/year for non-members), Annual Meeting registration and exhibitor/sponsorship fees, JITC article processing charges (with member discounts), and educational grants/sponsorships from industry partners such as Genentech. SITC operates a community-led, event-driven go-to-market motion that targets its professional audience through scientific exchange, continuing education, and the prestige of its awards program (including the Smalley Memorial Award and Academy of Immuno-Oncology fellowship).

Name

Society for Immunotherapy of Cancer (SITC)

Legal name

Society for Immunotherapy of Cancer

Website

https://sitcancer.org

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

11–50 employees

Short description

SITC is a 501(c)(6) nonprofit professional medical society founded in 1984 that serves the global cancer immunotherapy community through its annual meeting, peer-reviewed Journal for ImmunoTherapy of Cancer, SITC OnDemand video library, educational webinars, clinical practice guidelines, and tiered professional membership.

Ownership category

akta.pro rank

Headquarters

HQ city

Milwaukee

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: SITC generates revenue through annual membership dues across multiple categories including Regular ($400/year, $500 for industry), Affiliate, Emeritus ($100/year), Allied Health ($100/year), Student ($100/year), Patient Advocate ($100/year), Patient ($50/year), and LMIE ($0/year). Members receive access to SITC OnDemand, discounted meeting registration, APC discounts for JITC publications, and other professional benefits.
2. SITC OnDemand Subscriptions: Non-members can purchase standalone SITC OnDemand subscriptions for $600/year (industry), $500/year (non-member), $200/year (allied health), and $150/year (patient). Subscriptions provide access to 1,300+ sessions and 700+ hours of recorded educational content. No cancellations are accepted for subscriptions.
3. Annual Meeting Registration and Sponsorship: The annual meeting generates revenue through attendee registration fees (with member discounts), exhibitor booth fees, sponsorship packages, and advertising opportunities. The 40th Anniversary Annual Meeting in 2025 featured exhibitor opportunities with hybrid virtual booth options.
4. Journal for ImmunoTherapy of Cancer (JITC) - Article Processing Charges: SITC publishes the Journal for ImmunoTherapy of Cancer, an open access peer-reviewed journal. Authors, particularly non-members, pay article processing charges for publications. SITC members receive discounts on APCs.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

SITC is a nonprofit professional medical society that delivers membership services, educational programming, scientific publications, and professional certification in cancer immunotherapy. Its core sellable offerings include the flagship Annual Meeting and Pre-Conference Programs, the SITC OnDemand streaming video library, the Journal for ImmunoTherapy of Cancer (JITC), educational webinar series such as Advances in Cancer Immunotherapy, a Certificate in Cancer Immunotherapy, and specialized summits and workshops. Revenue is generated primarily through membership dues, event registration, sponsorships, publication article processing charges, and subscriptions.

Product overview

The Society for Immunotherapy of Cancer (SITC) is a professional membership organization, not a product company. Its offerings consist of membership-based services, educational programs, and scholarly publications. The core programs include the Annual Meeting (a major international conference), the Advances in Cancer Immunotherapy (ACI) webinar series, SITC OnDemand (streaming video library with 1,300+ sessions), the Journal for ImmunoTherapy of Cancer (JITC, an open-access peer-reviewed journal), Clinical Practice Guidelines, professional certification programs, fellowship/grant funding, and specialized summits covering topics like autoimmunity and computational immuno-oncology. These offerings serve the global immuno-oncology professional community through education, networking, and scientific publication.

Differentiator

Problem solved

Functional benefit

Brands

• Journal for ImmunoTherapy of Cancer (JITC): Open access, peer-reviewed journal producing original research articles, literature reviews, and content on tumor immunology and cancer immunotherapy
• SITC OnDemand
• Advances in Cancer Immunotherapy (ACI)
• Cancer Immunotherapy Principles and Practice

Products and services

• SITC Annual Meeting & Pre-Conference Programs The flagship annual conference bringing together international leaders in cancer immunotherapy from academia, government, and industry for education, scientific exchange, and networking, including pre-conference programs such as the World Immunotherapy Council Symposium, Regulatory Roundtable, and workshops.
• SITC OnDemand A curated video streaming library of recorded sessions from SITC Annual Meetings, webinars, and expert series, with 1,300+ sessions and 700+ hours of video content, featuring search, filter, bookmark, and follow-speaker capabilities. Included with SITC membership or available by standalone subscription for non-members.
• Journal for ImmunoTherapy of Cancer (JITC) An open access, peer-reviewed journal producing original research articles and literature reviews on tumor immunology and cancer immunotherapy, serving as the global voice of the society. Authors (particularly non-members) pay article processing charges for publication, with member discounts available.
• Advances in Cancer Immunotherapy (ACI) Series A series of live virtual webinars providing in-depth education on clinical implementation of cancer immunotherapy across various disease states including lung cancer, gastrointestinal cancers, neoadjuvant immunotherapy, and intratumoral therapies, featuring expert panels and case study reviews with CME credit available.
• Certificate in Cancer Immunotherapy A professional certification program enabling clinicians and researchers to demonstrate competency in cancer immunotherapy principles and practice.
• Cancer Immunotherapy Winter School An intensive educational program providing comprehensive training in cancer immunotherapy for clinicians and researchers.
• SITC IO-ACT PD-1xVEGF Summit A specialized summit focused on PD-1/VEGF bispecifics and combination therapies in immuno-oncology.
• SITC Autoimmunity and Immuno-Oncology Virtual Summit A virtual summit highlighting the emerging role of immunotherapies in treating autoimmune diseases and exploring the intersection of immuno-oncology and rheumatology.
• Computational Immuno-oncology Webinar Series A webinar series covering computational approaches in immuno-oncology including AI, foundation models, medical imaging, TCR-antigen binding prediction, and systems immunology, run by the Big Data and Data Sharing Committee.
• SITC Biotech Initiative Programs connecting biotech and pharmaceutical companies with the immuno-oncology community, including strategic meetings at NYSE and EU Immuno-Oncology Drug Development Summits.
• SITC Clinical Practice Guidelines (CPG) Evidence-based clinical practice guidelines developed by SITC to guide practitioners in the implementation of cancer immunotherapy treatments.

Quantifiable outcome

• Over 1,300 abstract submissions received for the 40th Anniversary Annual Meeting in 2025
• +2 more outcomes

Segments8 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core, major and regional.

• Partners for Advancing Clinical EducationcoreStrategic or Co-development Partner · 2 December 2026Joint accreditation partner for the Advances in Cancer Immunotherapy (ACI) series. Partners is jointly accredited by ACCME, ACPE, and ANCC to provide continuing education for healthcare teams including physicians, pharmacists, and nurses. This partnership enables SITC to offer accredited CME/CE programming.
• Advanced Practitioner Society for Hematology and Oncology (APSHO)majorStrategic or Co-development Partner · 2 December 2026Collaboration partner for the 2026 ACI series bringing advanced practitioners together with oncologists to advance immunotherapy education. APSHO represents nurse practitioners and physician assistants in hematology and oncology.
• Association of Cancer Care Centers (ACCC)majorStrategic or Co-development Partner · 2 December 2026Collaboration partner for the 2026 ACI series. ACCC represents the multidisciplinary cancer care team and provides education and advocacy for cancer programs across the United States.
• Agora Cancer Research CenterregionalStrategic or Co-development Partner · 3 September 2026Venue partner for the 2026 SITC EU Immuno-Oncology Drug Development Summit to be held September 3-4, 2026, at the Agora Cancer Research Center in Lausanne, Switzerland.
• Japanese Association of Cancer Immunology (JACI)regionalStrategic or Co-development Partner · 22 July 2026Collaborative education partner for the 30th Annual Meeting of JACI (JACI 2026) scheduled July 22-24, 2026, at Kagawa International Conference Center in Takamatsu, Japan. SITC supports collaborative programs with JACI.
• 6th World Immunotherapy Council (WIC)majorStrategic or Co-development PartnerSITC hosts the 6th World Immunotherapy Council Symposium as part of its Pre-Conference Programs at SITC 2025. The WIC brings together international immunotherapy societies to coordinate global efforts in cancer immunotherapy research and education.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• Xx.com/sitcancer
• Facebookfacebook.com/sitcancer

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Society for Immunotherapy of Cancer (SITC)